EXPONENT INC is 1.3x more valuable than Astrana Health, Inc. by market capitalization ($2.74 B vs $2.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ASTH | EXPO |
|---|---|---|
| Market cap | $2.16 B | $2.74 B |
| US-listed rank | #2049 | #1894 |
| Revenue (latest FY) | $3.18B | $582.01M |
| Net income (latest FY) | $24.00M | $106.01M |
| Net margin | 0.8% | 18.2% |
| P/E (trailing FY) | 89.9 | 25.8 |
| SEC filings | 1,003 | 2,029 |
EXPONENT INC is 1.3x more valuable than Astrana Health, Inc. by market capitalization ($2.74 B vs $2.16 B).
In their latest fiscal years, Astrana Health, Inc. reported $3.18B in revenue while EXPONENT INC reported $582.01M.
Full pages: Astrana Health, Inc. and EXPONENT INC, or browse the full rankings.